{{Rsnum
|rsid=10466829
|Gene=CLECL1
|Chromosome=12
|position=9723495
|Orientation=plus
|GMAF=0.4977
|Gene_s=CLECL1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 25.7 | 42.5 | 31.9
| HCB | 10.2 | 46.7 | 43.1
| JPT | 11.5 | 49.6 | 38.9
| YRI | 44.5 | 43.8 | 11.6
| ASW | 38.2 | 45.5 | 16.4
| CHB | 10.2 | 46.7 | 43.1
| CHD | 9.2 | 52.3 | 38.5
| GIH | 30.7 | 47.5 | 21.8
| LWK | 45.5 | 47.3 | 7.3
| MEX | 19.0 | 46.6 | 34.5
| MKK | 45.5 | 43.6 | 10.9
| TSI | 33.3 | 45.1 | 21.6
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21833088
|Trait=None
|Title=Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.
|RiskAllele=A
|Pval=1E-8
|OR=1.0900
|ORtxt=[1.08-1.11]
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}